331 related articles for article (PubMed ID: 35158794)
1. Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring.
Mäkinen L; Vähä-Koskela M; Juusola M; Mustonen H; Wennerberg K; Hagström J; Puolakkainen P; Seppänen H
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158794
[TBL] [Abstract][Full Text] [Related]
2. Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy.
Gong M; Meng H; Tan D; Li P; Qin J; An Q; Shi C; An J
Animal Model Exp Med; 2023 Oct; 6(5):409-418. PubMed ID: 37890865
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
Sereti E; Papapostolou I; Dimas K
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979869
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids.
Palzer J; Mues B; Goerg R; Aberle M; Rensen SS; Olde Damink SWM; Vaes RDW; Cramer T; Schmitz-Rode T; Neumann UP; Slabu I; Roeth AA
Int J Nanomedicine; 2021; 16():2965-2981. PubMed ID: 33935496
[TBL] [Abstract][Full Text] [Related]
5. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells.
Choi JI; Jang SI; Hong J; Kim CH; Kwon SS; Park JS; Lim JB
Cancer Lett; 2021 Feb; 498():42-53. PubMed ID: 33188841
[TBL] [Abstract][Full Text] [Related]
6. A pancreas tumor derived organoid study: from drug screen to precision medicine.
Yao J; Yang M; Atteh L; Liu P; Mao Y; Meng W; Li X
Cancer Cell Int; 2021 Jul; 21(1):398. PubMed ID: 34315500
[TBL] [Abstract][Full Text] [Related]
7. OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data.
Ferreira N; Kulkarni A; Agorku D; Midelashvili T; Hardt O; Legler TJ; Ströbel P; Conradi LC; Alves F; Ramos-Gomes F; Markus MA
Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38805131
[TBL] [Abstract][Full Text] [Related]
8. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma.
Kang Y; Deng J; Ling J; Li X; Chiang YJ; Koay EJ; Wang H; Burks JK; Chiao PJ; Hurd MW; Bhutani MS; Lee JH; Weston BR; Maitra A; Ikoma N; Tzeng CD; Lee JE; DePinho RA; Wolff RA; Pant S; McAllister F; Katz MH; Fleming JB; Kim MP
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282600
[TBL] [Abstract][Full Text] [Related]
9. Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models.
Tiriac H; French R; Lowy AM
J Vis Exp; 2020 Jan; (155):. PubMed ID: 32009658
[TBL] [Abstract][Full Text] [Related]
10. Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer.
Haque MR; Rempert TH; Al-Hilal TA; Wang C; Bhushan A; Bishehsari F
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503294
[TBL] [Abstract][Full Text] [Related]
11. Organoid models for translational pancreatic cancer research.
Tiriac H; Plenker D; Baker LA; Tuveson DA
Curr Opin Genet Dev; 2019 Feb; 54():7-11. PubMed ID: 30844513
[TBL] [Abstract][Full Text] [Related]
12. Testing Susceptibility of Patient-Derived Organoid Cultures to Therapies: Pharmacotyping.
Burkhart RA; Baker LA; Tiriac H
Methods Mol Biol; 2018; 1787():253-261. PubMed ID: 29736724
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine.
Frappart PO; Hofmann TG
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987786
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer.
Kumano K; Nakahashi H; Louphrasitthiphol P; Kuroda Y; Miyazaki Y; Shimomura O; Hashimoto S; Akashi Y; Mathis BJ; Kim J; Owada Y; Goding CR; Oda T
Front Cell Dev Biol; 2024; 12():1327772. PubMed ID: 38374892
[TBL] [Abstract][Full Text] [Related]
15. Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions.
Suri R; Zimmerman JW; Burkhart RA
Ann Pancreat Cancer; 2020 Dec; 3():. PubMed ID: 33889840
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Organoids for Regenerative Medicine and Cancer Research.
Casamitjana J; Espinet E; Rovira M
Front Cell Dev Biol; 2022; 10():886153. PubMed ID: 35592251
[TBL] [Abstract][Full Text] [Related]
17. The application of pancreatic cancer organoids for novel drug discovery.
Melzer MK; Resheq Y; Navaee F; Kleger A
Expert Opin Drug Discov; 2023 Apr; 18(4):429-444. PubMed ID: 36945198
[TBL] [Abstract][Full Text] [Related]
18. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
[TBL] [Abstract][Full Text] [Related]
19. In-vitro model to mimic T cell subset change in human PDAC organoid co-culture.
Knoblauch M; Ma T; Beirith I; Koch D; Hofmann F; Heinrich K; Aghamaliev U; Sirtl S; Westphalen CB; Nieß H; Reichert M; Angele MK; Regel I; Bazhin AV; Werner J; Ilmer M; Renz BW
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13051-13064. PubMed ID: 37470855
[TBL] [Abstract][Full Text] [Related]
20. Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology.
Zeöld A; Sándor GO; Kiss A; Soós AÁ; Tölgyes T; Bursics A; Szűcs Á; Harsányi L; Kittel Á; Gézsi A; Buzás EI; Wiener Z
Cell Mol Life Sci; 2021 Mar; 78(6):3005-3020. PubMed ID: 33237353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
